Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Jun. 30, 2021
Current assets:    
Cash $ 280,877 $ 1,041,899
Accounts receivable (net of allowance of $0 and $0, respectively) 93,674 109,589
Inventory 331,531 387,736
Other current asset 137,797 33,480
Total current assets 843,879 1,572,704
Total assets 843,879 1,572,704
Current liabilities:    
Accounts payable 234,152 459,703
Accrued expense - related party 3,000
Convertible notes payable - net of discounts 344,151
Total current liabilities 578,303 462,703
Commitments and contingencies
Stockholders’ equity:    
Series A Stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of June 30, 2022 and June 30, 2021, respectively) 1 1
Series B Stock, ($0.001 par value, 5,000 shares authorized, and 3,260 and 4,665 issued and outstanding as of June 30, 2022 and June 30, 2021, respectively) 3 5
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 91,814,484 issued and outstanding as of June 30, 2022 and 80,707,467 issued and outstanding as of June 30, 2021, respectively) 91,814 80,707
Additional paid in capital 28,275,216 26,226,159
Accumulated deficit (28,101,458) (25,196,871)
Total Stockholders’ Equity 265,576 1,110,001
Total Liabilities and Stockholders’ Equity $ 843,879 $ 1,572,704